Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 111
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Daratumumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Yuma, Arizona
  • +150 more
Dec 9, 2022

Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +8 more
Nov 30, 2022

Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +139 more
Sep 9, 2022

Maintenance With Bortezomib Plus Daratumumab After Induction

Recruiting
  • Multiple Myeloma
  • Non-eligible for Autologous Stem Cell Transplantation (ASCT)
  • Arganda Del Rey, Spain
  • +31 more
Sep 15, 2022

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

Active, not recruiting
  • Multiple Myeloma
  • +5 more
  • Duarte, California
  • +38 more
Aug 18, 2022

Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Orlando, Florida
  • +240 more
Aug 18, 2022

Multiple Myeloma Trial in Worldwide (REGN5458)

Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +26 more
Aug 16, 2022

Multiple Myeloma Trial in Worldwide (Cilta-cel)

Recruiting
  • Multiple Myeloma
  • Phoenix, Arizona
  • +30 more
Aug 11, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab Subcutaneous (SC) Administration, Recombinant Human Hyaluronidase [rHuPH20]) SC

Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
Aug 11, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Carfilzomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Nantes Cedex 1, France
  • +19 more
Aug 11, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Woolloongabba, Queensland, Australia
  • +117 more
Aug 3, 2022

Multiple Myeloma Trial in Worldwide (Selinexor, Elotuzumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +67 more
Jul 26, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
Jul 27, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma of Bone Trial in Worldwide (HPN217)

Recruiting
  • Multiple Myeloma in Relapse
  • +3 more
  • Gilbert, Arizona
  • +17 more
Jul 21, 2022

Multiple Myeloma Trial in Worldwide (PHE885)

Recruiting
  • Multiple Myeloma
  • PHE885
  • VIC, Melbourne, Australia
  • +4 more
Jul 20, 2022

Multiple Myeloma Trial in Worldwide (CTX120)

Active, not recruiting
  • Multiple Myeloma
  • CTX120
  • Chicago, Illinois
  • +9 more
Jul 14, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Tucson, Arizona
  • +131 more
Jul 1, 2022

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Hematopoietic Stem Cell Transplantation, Multiple Myeloma Trial in Spain (Ixazomib, Tacrolimus, Sirolimus)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma
  • Badalona, Spain
  • +7 more
May 20, 2022

Multiple Myeloma Trial in Worldwide (isatuximab SAR650984 IV, pomalidomide, dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • isatuximab SAR650984 IV
  • +4 more
  • Gilbert, Arizona
  • +14 more
May 6, 2022

Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

Recruiting
  • Hematological Malignancies
  • +3 more
  • Phoenix, Arizona
  • +19 more
Apr 12, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Pom/dex (Pomalidomide plus low dose Dexamethasone)
  • Tucson, Arizona
  • +163 more
Feb 25, 2022

Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone, Bortezomib)

Terminated
  • Multiple Myeloma
  • Melphalan flufenamide (Melflufen)
  • +3 more
  • Boston, Massachusetts
  • +15 more
Mar 4, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Adelaide, Australia
  • +51 more
Feb 16, 2022

Presentation, Treatment Patterns, and Outcomes in Multiple

Completed
  • Multiple Myeloma
  • No Intervention
  • Little Rock, Arkansas
  • +136 more
Feb 15, 2022